Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Nov 19, 2019 10:28am

87 Views

Post# 30369194

RE:RE:RE:RE:RE:OPPORTUNITIES

Hi Claridge - believe NMIBC is forecast to be a $1.3bn market but don`t know how much % TLT would take or at what unit price - i.e.have no clue as to the revenue to which to apply a p/e but gut feeling is that the value of standard of care will be $3bn upwards on the first indication alone.We already know that we should have a Phase 1B from another indication by the time NMIBC is commercialised so the momentum will already be there and if this is perceived as a must-have disruptive technology then the force will be with us - hopefully sooner than we think!

Bullboard Posts

Pharmaceuticals Co. grows global reach to meet unique medical need